InspireMD董事Raymond W. Cohen因個人因素辭職 7月1日生效

false
 0001433607
 
 
 
 
 
 
 
 0001433607
 
 
 2026-06-26
 2026-06-26
 
 
 
 iso4217:USD
 
 
 xbrli:shares
 
 
 
 
 iso4217:USD
 
 
 xbrli:shares
 
 
 
 
 

 

 

 

UNITED
STATES

SECURITIES
AND EXCHANGE COMMISSION

Washington,
D.C. 20549

 

 

 

FORM
8-K

 

 

 

CURRENT
REPORT

Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date
of Report (Date of earliest event reported): June 26,
2026

 

 

 

InspireMD,
Inc.

(Exact
name of registrant as specified in its charter)

 

 

 

 
 Delaware
  
 001-35731
  
 26-2123838

 
 (State
 or other jurisdiction

 of incorporation)
  
 (Commission

 File Number)
  
 (IRS
 Employer

 Identification No.)

 
 

 
 6303
 Waterford District Drive,
 Suite
 215

 Miami,
 Florida 33126

  
 6744832

 
 (Address
 of principal executive offices)
  
 (Zip
 Code)

 
 

Registrant’s
telephone number, including area code: (888)
776-6804

 

 

(Former
name or former address, if changed since last report.)

 

 

 

Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:

 

 
 ☐
 Written
 communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 
  
  

 
 ☐
 Soliciting
 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 
  
  

 
 ☐
 Pre-commencement
 communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 
  
  

 
 ☐
 Pre-commencement
 communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

Securities
registered pursuant to Section 12(b) of the Act:

 

 
 Title
 of each class
  
 Trading
 Symbol(s)
  
 Name
 of each exchange on which registered

 
 Common
 Stock, $0.0001 par value per share
  
 NSPR
  
 The
 Nasdaq Capital Market

 
 

Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging
growth company ☐

 

If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

  

  

 

 

Item
5.02. Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On
June 26, 2026, Mr. Raymond W. Cohen, a Class III member of the board of directors (the “Board”) of InspireMD, Inc. (the “Company”),
a member of the Audit Committee of the Board and a member of the Compensation Committee of the Board, tendered his resignation from the
Board, effective July 1, 2026. Mr. Cohen’s resignation from the Board was for personal considerations and not due to any disagreement
with the Company, the Board or the management of the Company on any matter relating to the Company’s operations, policies, practices
or otherwise.

 

The
Nominating and Corporate Governance Committee of the Board intends to identify and evaluate suitable candidates to fill the vacancy created
by Mr. Cohen’s resignation.

 

Item
9.01 Financial Statements and Exhibits.

 

(d)
Exhibits.

 

 
 Exhibit
 Number
  
 Description

 
 104
  
 Cover
 Page Interactive Data File (embedded within the Inline XBRL document)

 
 

  

  

 

 

SIGNATURES

 

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

 

 
  
 INSPIREMD,
 INC.

 
  
  
  

 
 Date:
 July 2, 2026
 By:
 /s/
 Marvin Slosman

 
  
 Name:
 Marvin
 Slosman

 
  
 Title:
 Chief
 Executive Officer